Global drug giant boosts Boulder biotech's funding round to $150 million
The company's molecular research and drug-development platform taps what it calls nature's wisdom to drive the discovery of ...
Pharmabiz2d
Enveda gets support from Sanofi to advance AI-driven drug discovery to clinical trials
Enveda gets support from Sanofi to advance AI-driven drug discovery to clinical trials: Boulder, Colorado Friday, February 28, 2025, 16:00 Hrs [IST] Enveda, a leading biotechnolog ...
Yahoo Finance28d
Sanofi kicks off share buyback plan with $3bn L’Oréal stake purchase
Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L'Oréal, the first of multiple share buybacks the French drugmaker has planned for 2025. L'Oréal was selling 29,556,650 ...
Wall Street Journal27d
L’Oreal to Sell $3.1 Billion Stake in Sanofi Back to Pharma Group
L’Oreal OR0.00%increase; green up pointing triangle will sell part of its stake in Sanofi SAN 0.70%increase; green up pointing triangle back to the French pharmaceutical company for 3 billion ...
pharmaphorum4d
Sanofi says new drugs can add €10bn to sales by 2030
Sanofi said this morning that its pipeline includes 12 potential blockbuster drugs that could generate more than €10 billion ($11 billion) in annual sales by the end of the decade, a sharp ...
Reuters1mon
Sanofi plans share buybacks, signals more deals post Opella sale
Sanofi could be "bit more" active with M&A in near future, CFO says Sanofi's R&D spending to see limited increase in 2025 Beyfortus sales double, Dupixent sales miss estimates Jan 30 - Sanofi ...
Nature1y
Unlocking the natural world to search for new medicines
While many drug companies avoid targets deemed ‘undruggable’, US-based Enveda Biosciences attacks them head on. Founded in 2019, Enveda uses unique libraries and machine-learning technologies ...